Fluence Corporation reports $0.5 million Q1 2026 EBITDA

Fluence Corporation Limited delivered a $0.5 million EBITDA in the first quarter of fiscal 2026, outperforming the prior period's breakeven result during a traditionally slow quarter. CEO Benjamin Fash attributed the performance to strong execution on backlog, improved gross margins, and cost discipline. However, orders totaled just $7.5 million due to delays.

Fluence Corporation held its Q1 FY 2026 earnings webcast on April 29, 2026. Benjamin Fash, CEO and Managing Director, provided an overview of the results, joined by CFO Osvaldo Llanes and Investor Relations head Andrew Angus. Fash noted the company's recent release of its Q1 business update and Appendix 4C filing.

관련 기사

Illustration of Adobe's financial success with revenue charts and AI elements in a corporate setting.
AI에 의해 생성된 이미지

Adobe reports record Q2 revenue and raises full-year guidance

AI에 의해 보고됨 AI에 의해 생성된 이미지

Adobe posted strong second-quarter results for fiscal 2026, with revenue reaching a record $6.62 billion. The company beat estimates and increased its full-year revenue outlook amid accelerating AI-driven growth.

Dragonfly Energy Holdings Corp. held its Q1 2026 earnings call on May 14. Executives said results exceeded guidance for net sales and adjusted EBITDA despite a softer RV market.

AI에 의해 보고됨

Firefly Aerospace Inc. conducted its first quarter 2026 financial results conference call on May 4. CEO Jason Kim and CFO Darren Ma joined Director of Investor Relations Michael Sheetz to discuss results for the period ending March 31. The call included forward-looking statements and both GAAP and non-GAAP financial measures.

Bouygues SA released its slide deck for the first quarter of 2026 earnings call on May 7.

AI에 의해 보고됨

Forgent Power Solutions, Inc. conducted its third fiscal quarter 2026 earnings conference call on May 14. The session featured remarks from senior executives and included standard forward-looking statements.

Nuvation Bio Inc. conducted its first quarter 2026 earnings call on May 4, 2026. The company reviewed financial results for the period ending March 31, 2026, and provided a business update. Executives including CEO David Hung participated in the discussion.

AI에 의해 보고됨

Aytu BioPharma conducted its earnings call for the fiscal 2026 third quarter on May 13, 2026. Executives discussed operational and financial results for the period ended March 31, 2026.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부